In This Article:
As European markets continue to rally, buoyed by slower inflation and potential interest rate cuts, investors are increasingly looking toward growth stocks with strong insider ownership as a sign of confidence and stability. In this context, identifying companies where insiders hold significant stakes can be particularly compelling, as it often indicates alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Truecaller (OM:TRUE B) | 29.5% | 21.6% |
Fortnox (OM:FNOX) | 21.1% | 22.6% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.8% | 73.1% |
BioArctic (OM:BIOA B) | 34% | 98.4% |
Yubico (OM:YUBICO) | 37.5% | 42.5% |
KebNi (OM:KEBNI B) | 37.8% | 86.1% |
InCoax Networks (OM:INCOAX) | 19% | 115.5% |
Calliditas Therapeutics (OM:CALTX) | 12.7% | 51.9% |
Let's uncover some gems from our specialized screener.
Humble Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Humble Group AB (publ) refines, develops, and distributes fast-moving consumer products in Sweden and internationally, with a market cap of SEK5.46 billion.
Operations: Humble Group AB (publ) generates revenue from four primary segments: Future Snacking (SEK950 million), Sustainable Care (SEK2.30 billion), Quality Nutrition (SEK1.53 billion), and Nordic Distribution (SEK2.67 billion).
Insider Ownership: 13%
Humble Group AB (publ) has shown substantial insider buying over the past three months, with no significant insider selling. Recent earnings reports indicate positive trends, with Q2 2024 sales at SEK 1.86 billion and net income of SEK 32 million. The company also secured an amendment agreement to increase its credit facilities by SEK 300 million. Despite a forecasted revenue growth of 11.5% per year, Humble is trading at a good value compared to its peers and industry.
Medicover
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK27.84 billion.
Operations: Medicover's revenue is primarily derived from Healthcare Services (€1.32 billion) and Diagnostic Services (€610 million).
Insider Ownership: 11.1%
Medicover AB (publ) has demonstrated strong growth with Q2 2024 sales reaching €509.4 million, up from €424.7 million a year ago, and net income rising to €6.3 million from €5.5 million. The company expects organic revenue to exceed €2.2 billion by year-end 2025 and forecasts annual earnings growth of 38.56%. Recent executive changes include the appointment of Anand Patel as CFO, bringing extensive experience in international finance and business management from the retail sector.